clenbuterol has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meister, J | 1 |
| Bone, DBJ | 1 |
| Knudsen, JR | 1 |
| Barella, LF | 1 |
| Liu, L | 1 |
| Lee, R | 1 |
| Gavrilova, O | 1 |
| Chen, M | 1 |
| Weinstein, LS | 1 |
| Kleinert, M | 1 |
| Jensen, TE | 1 |
| Wess, J | 1 |
1 other study available for clenbuterol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
In vivo metabolic effects after acute activation of skeletal muscle G
Topics: Animals; Clenbuterol; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; GTP-Binding P | 2022 |